Shrimp Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global shrimp disease diagnostics market is undergoing rapid transformation, driven by rising shrimp consumption, increasing disease outbreaks, and advancements in diagnostic technologies. As shrimp continues to dominate the aquaculture sector, timely disease detection has become paramount. According to recent industry assessments, the market is projected to grow from US$ 535 million in 2025 to US$ 1,210 million by 2032, expanding at a strong CAGR of 12.37% during the forecast period.

Market Insights

Shrimp farming is one of the most critical components of global aquaculture. However, recurrent disease outbreaks such as White Spot Syndrome and other viral infections have had severe economic repercussions. With shrimp being a primary source of seafood globally, the demand for advanced diagnostics to ensure shrimp health and sustainable farming is at an all-time high. The shrimp disease diagnostics market, as a niche within the larger animal diagnostics sector, is thus witnessing increased attention, innovation, and investment.

Assay-based kits currently dominate the market due to their high sensitivity, reliability, and ability to detect multiple pathogens in a single test. The shift from centralized laboratory diagnostics to field-deployable diagnostic solutions is also enhancing early detection capabilities, thereby supporting better disease control and management strategies.

Market Drivers

Key factors propelling the growth of the shrimp disease diagnostics market include:

• Growing Global Shrimp Consumption: Shrimp is one of the most widely consumed seafood items worldwide. The increasing demand necessitates effective disease management solutions.

• Frequent Disease Outbreaks: Diseases like White Spot Syndrome Virus (WSSV), Yellow Head Virus (YHV), and Infectious Myonecrosis Virus (IMNV) have repeatedly disrupted shrimp farming, creating urgency for early diagnostics.

• Technological Advancements: The integration of PCR, ELISA, and CRISPR-based technologies has significantly enhanced the speed and accuracy of disease detection.

• Biosecurity Measures: Diagnostic tools play a vital role in maintaining the biosecurity of shrimp farms, preventing disease spread, and ensuring food safety.

• Government Regulations: Increased regulations on seafood quality are boosting the demand for high-standard diagnostic services.

Regional Analysis

The growing emphasis on sustainable aquaculture, food safety, and disease prevention presents a lucrative opportunity for diagnostic solution providers. Emerging markets, particularly in Asia and Latin America, are expected to drive future demand due to the high concentration of shrimp farming operations. Companies investing in affordable, easy-to-use diagnostic kits for field use are poised to capture a significant share of this evolving market.

Additionally, partnerships with academic and government institutions are helping businesses develop validated diagnostic tools, expanding product portfolios, and facilitating regulatory approvals.

Region Analysis

• United States: The U.S. market is expected to remain promising owing to its robust infrastructure, advanced molecular diagnostic tools, and strong governmental support for sustainable aquaculture.

• China: As the world’s largest producer and consumer of aquacultured shrimp, China’s market is growing rapidly. Stringent quality regulations and a focus on avoiding economic losses from shrimp disease outbreaks are accelerating diagnostic adoption.

• Germany: A prominent market in Europe, Germany benefits from a strong seafood farming sector and the presence of key industry players. This has led to greater competition and product availability, encouraging further market expansion.

Key Players

Prominent companies are actively investing in R&D and strategic collaborations to develop cutting-edge diagnostic tools. Noteworthy developments include:

• Seek Labs launched a field-deployable WSSV detection kit, proven to be cost-effective and highly accurate.

• Genics introduced Shrimp MultiPath 2.0, capable of detecting 18 shrimp pathogens in one test.

• Sherlock Biosciences and Gloucester Marine Genomics Institute (GMGI) are collaborating on CRISPR-based diagnostics, funded by the USDA, aimed at field-use detection of aquaculture pathogens.

These developments signify a competitive market Analysis where innovation and rapid deployment are key differentiators.

Market Segmentation

By Reagent:

• Rapid Testing Kits

• Assay Based Kits

By Disease:

• White Spot Syndrome Virus (WSSV)

• Taura Syndrome Virus (TSV)

• Yellow Head/Gill Associated Virus (YHV/GAV)

• Infectious Hypodermal and Hematopoietic Virus (IHHNV)

• Hepatopancreatic Parvovirus (HPV)

• Monodon Baculovirus (MBV)

• Infectious Myonecrosis Virus (IMNV)

• Necrotising Hepatopancreatitis Bacteria (NHP-B)

• Mourilyan Virus (MoV)

• Early Mortality Syndrome (EMS)

By End User:

• Fisheries

• Aquaculture Laboratories

• Marine Laboratories

• Education and Research Institutes

• Others

By Region:

• North America

• Latin America

• Europe

• South Asia

• East Asia

• Oceania

• Middle East and Africa

Please note: Delivery Timelines - 5 working days.